APA (7th ed.) Citation

BA, N., HL, M., AR, M., F, Y., B, M., S, A., . . . AJ, S. (2025). The Magnitude of Polypharmacy and Role of Disease Severity and Patient Sex in Medication Use Among Patients With MASLD Enrolled in TARGET-NASH. Alimentary pharmacology & therapeutics, 62(9), 920. https://doi.org/10.1111/apt.70278

Chicago Style (17th ed.) Citation

BA, Neuschwander-Tetri, et al. "The Magnitude of Polypharmacy and Role of Disease Severity and Patient Sex in Medication Use Among Patients With MASLD Enrolled in TARGET-NASH." Alimentary Pharmacology & Therapeutics 62, no. 9 (2025): 920. https://doi.org/10.1111/apt.70278.

MLA (9th ed.) Citation

BA, Neuschwander-Tetri, et al. "The Magnitude of Polypharmacy and Role of Disease Severity and Patient Sex in Medication Use Among Patients With MASLD Enrolled in TARGET-NASH." Alimentary Pharmacology & Therapeutics, vol. 62, no. 9, 2025, p. 920, https://doi.org/10.1111/apt.70278.